Sponsor of the Day:
Jerkmate
https://www.sciencemediacentre.org/expert-reaction-to-meta-analysis-and-modelling-study-on-weight-regain-after-stopping-glp-1-receptor-agonists/
expert reaction to meta-analysis and modelling study on weight regain after stopping GLP-1 receptor...
glp 1 receptorexpert reactionmeta analysismodellingstudy
https://www.jci.org/articles/view/194745
JCI - The promise of GLP-1 receptor agonists for neurodegenerative diseases
glp 1 receptorneurodegenerative diseasesjcipromiseagonists
https://www.jci.org/articles/view/194740
JCI - The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and...
glp 1 receptoradverse effectsjcisciencesafety
https://cliffordclinic.com/body/glp-1-receptor-agonists-weight-loss-singapore/
GLP-1 Receptor Agonists for Weight Management
Nov 3, 2025 - Learn about the GLP-1 receptor agonist injections for weight management, including injection areas, technique, safety tips, and doctor supervision at The...
glp 1 receptorweight managementagonists
https://www.aoa.org/news/clinical-eye-care/public-health/glp-1-receptor-agonists-and-vision-risk
GLP-1 Receptor Agonists and vision risk
A new AOA report highlights rare but serious ocular complications.
glp 1 receptoragonistsvisionrisk
https://efim.org/video/glp-1-receptor-agonists-applications-clinical-practice
GLP-1 Receptor Agonists: Applications in Clinical Practice | European Federation of Internal...
The EFIM Young Internists and the Austrian Young Internists hosted the webinar
glp 1 receptorclinical practiceeuropean federationagonistsapplications
https://www.paho.org/en/documents/epidemiological-alert-misuse-glp-1-receptor-agonist-medications-and-considerations
Epidemiological Alert: Misuse of GLP-1 receptor agonist medications and considerations for the...
In recent months, there has been an increase in the number of countries reporting adverse effects of varying severity associated with the misuse of...
glp 1 receptorepidemiological alertmisuseagonistmedications
https://www.jci.org/articles/view/194743
JCI - GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities...
jci glp 1receptor agonistscancer currentclinical evidencetranslational
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1736380/full
Frontiers | Reassessing cancer risk with GLP-1 receptor agonists: a comprehensive meta-analysis of...
Apr 27, 2026 - Background and ObjectivesGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely prescribed for type 2 diabetes mellitus (T2DM) and obesity. While t...
glp 1 receptorcancer riskmeta analysisfrontiersreassessing
https://www.prnewswire.co.uk/news-releases/glp-1-receptor-agonist-market-to-hit-usd-78-4-billion-by-2032--growing-at-a-cagr-of-3-66-with-rising-demand-for-metabolic-disease-therapies--markntel-advisors-302714587.html
GLP-1 Receptor Agonist Market to Hit USD 78.4 Billion by 2032, Growing at a CAGR of 3.66% with...
Mar 17, 2026 - /PRNewswire/ -- According to the in-depth study published by MarkNtel Advisors, the Global GLP-1 Receptor Agonist Market is projected to grow at a CAGR of...
glp 1 receptorhit usd4 billion3 66agonist
https://link.springer.com/article/10.1038/s41443-026-01254-3?error=cookies_not_supported&code=ec7ede38-1d2d-4b64-bd17-58318774cc05
GLP-1 receptor agonists and male sexual health: Translating cardiometabolic benefits into erectile...
glp 1 receptormale sexual healthagoniststranslatingcardiometabolic
https://www.nature.com/articles/s41591-025-03542-9?error=cookies_not_supported&code=f076d330-f55e-420c-8c11-290bb86adeaa
Author Correction: Mapping the effectiveness and risks of GLP-1 receptor agonists | Nature Medicine
glp 1 receptorauthor correctionnature medicinemappingeffectiveness
https://consultqd.clevelandclinic.org/glp-1-receptor-agonists-slow-aaa-progression
GLP-1 Receptor Agonists Slow AAA Progression
Apr 10, 2026 - A large observational study suggests GLP-1 receptor agonists may hold potential as first medical therapy for abdominal aortic aneurysms.
glp 1 receptoragonistsslowaaaprogression
https://www.iasusa.org/events/webinar-2026-wooten/
GLP-1 Receptor Agonists in People With HIV: Emerging Evidence and Clinical Implications - IAS-USA
glp 1 receptorclinical implicationsias usaagonistspeople
https://canadiananabolics.is/product/syn-semaglutide/
SYN - Semaglutide - GLP-1 Receptor Agonist (Ozempic) 5mg
Oct 17, 2025 - Looking to Buy SYN - Semaglutide - GLP-1 Receptor Agonist (Ozempic) 5mg Online? | Buy Steroids Canada | Syn Pharma - Your Best Source.
glp 1 receptorsynsemaglutideagonistozempic
https://www.jci.org/articles/view/194745/pdf
JCI - The promise of GLP-1 receptor agonists for neurodegenerative diseases
glp 1 receptorneurodegenerative diseasesjcipromiseagonists
https://www.healthday.com/healthpro-news/allergies/aaaai-glp-1-receptor-agonists-linked-to-reduction-in-asthma-exacerbation-risk
GLP-1 Receptor Agonist Tied to Reduction in Asthma Exacerbation Risk
Mar 6, 2026 - Glucagon-like peptide-1 receptor agonist treatment is associated with reduced asthma exacerbation risk among individuals with overweight or obesity, without...
glp 1 receptoragonisttiedreductionasthma
https://www.jci.org/articles/view/194740/pdf
JCI - The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and...
glp 1 receptoradverse effectsjcisciencesafety
https://aaos-annualmeeting-presskit.org/2026/research-news/studies-explore-glp-1-receptor-agonist-use-and-its-impact-on-long-term-musculoskeletal-health/
Studies explore: GLP-1 receptor agonist use and its impact on long-term musculoskeletal health -...
Mar 6, 2026 - NEW ORLEANS (March 2, 2026)—The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide, has expanded rapidly among patients with...
glp 1 receptorstudies explorelong termmusculoskeletal healthagonist